Updates

First to the future of cardiac PET

10
May

David R. Langston, SBN #11923800

Brad W. Odell, SBN #24065839

Mullin Hoard & Brown, LLP

P.O. Box 2585

Lubbock, TX 79408

Tel: 806-765-7491

Fax: 806-765-0553

drl@mhba.com

bodell@mhba.com

www.mullinhoard.com
Attorneys for Positron Corporation

 

IN THE UNITED STATES BANKRUPTCY COURT

FOR THE... Read More

05
May

Nuclear medicine market to hit $2.2B by 2020

May 1, 2015 -- (AuntMinnie.com)  The worldwide nuclear medicine imaging market for PET and SPECT equipment is on track to produce $2.2 billion in revenues by 2020, according to a new report by RnR Market Research.

Two Asian giants will lead growth opportunities, with the Japanese market share set to increase by... Read More

06
Apr

Cardiovascular Disease Deaths Increasing Worldwide

THURSDAY, April 2, 2015 (HealthDay News) -- Despite medical advances, new research indicates that more people are dying of heart disease and stroke worldwide than did a quarter century ago because the global population is growing, and growing older. The study is published in the April 2 issue of the New England... Read More

18
Mar

March 10, 2015 — The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear medicine in the future will come through therapeutic radiopharmaceuticals (radiotherapeutics). Revenue for Xofigo – a product used in the... Read More

18
Mar

PET/CT Trumps SPECT for Cardiac Studies

March 17, 2015 -- Researchers from Utah found that PET/CT is far superior to SPECT for diagnosing myocardial ischemia, with higher sensitivity at a lower radiation dose, according to a paper presented on Sunday at the American College of Cardiology (ACC) meeting in San Diego. PET/CT in particular far outstripped... Read More

16
Mar

TWST Interview with Positon’s President & Chairman

The Wall Street Transcript releases an interview with Positron's President & Chairman, Joseph G. Oliverio.

TWST: Can you provide an overview of Positron and summarize its value proposition?
Mr. Oliverio: We are a nuclear medicine health care company that specializes in the businesses of positron emission... Read More